Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Nov;171(5):1265-1282.
doi: 10.1002/ohn.835. Epub 2024 Jun 6.

Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis

Kelsey A Duckett et al. Otolaryngol Head Neck Surg. 2024 Nov.

Abstract

Objective: Initiating postoperative radiotherapy (PORT) within 6 weeks of surgery for head and neck squamous cell carcinoma (HNSCC) is included in the National Comprehensive Cancer Network Clincal Practice Guidelines and is a Commission on Cancer quality metric. Factors associated with delays in starting PORT have not been systematically described nor synthesized.

Data sources: PubMed, Scopus, and CINAHL.

Review methods: We included studies describing demographic characteristics, clinical factors, or social determinants of health associated with PORT delay (>6 weeks) in patients with HNSCC treated in the United States after 2003. Meta-analysis of odds ratios (ORs) was performed on nonoverlapping datasets.

Results: Of 716 unique abstracts reviewed, 21 studies were included in the systematic review and 15 in the meta-analysis. Study sample size ranged from 19 to 60,776 patients. In the meta-analysis, factors associated with PORT delay included black race (OR, 1.46, 95% confidence interval [CI]: 1.28-1.67), Hispanic ethnicity (OR, 1.37, 95% CI, 1.17-1.60), Medicaid or no health insurance (OR, 2.01, 95% CI, 1.90-2.13), lower income (OR, 1.38, 95% CI, 1.20-1.59), postoperative admission >7 days (OR, 2.92, 95% CI, 2.31-3.67), and 30-day hospital readmission (OR, 1.37, 95% CI, 1.29-1.47).

Conclusion: Patients at greatest risk for a delay in initiating guideline-adherent PORT include those who are from minoritized communities, of lower socioeconomic status, and experience postoperative challenges. These findings provide the foundational evidence needed to deliver targeted interventions to enhance equity and quality in HNSCC care delivery.

Keywords: Commission on Cancer; National Comprehensive Cancer Network; adjuvant therapy; head and neck cancer; health equity; quality; radiotherapy; social determinants of health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors report the following funding, financial relationships, and conflicts of interest: Evan M. Graboyes: Consulting fees and research support from Castle Biosciences. Bhisham S. Chera MD: Co-inventor of intellectual property held by the University of North Carolina regarding the ctHPVDNA detection methodology (US Patent 11,168,373). The scientific advisor with ownership interest in Naveris Inc, a company that has licensed ctHPVDNA technology from the University of North Carolina for commercialization. Vlad C. Sandulache: Consulting fees for Femtovox Inc. Nosayaba Osazuwa-Peters: Scientific advisor to Navigating Cancer. Expert fees from Merck.

Similar articles

Cited by

References

    1. Graboyes EM, Divi V, Moore BA. Head and neck oncology is on the national quality sidelines no longer—put me in, coach. JAMA Otolaryngol Head Neck Surg. 2022;148(8):715–716. doi:10.1001/jamaoto.2022.1389 - DOI - PMC - PubMed
    1. Caudell JJ, Gillison ML, Maghami E, et al. NCCN Guidelines® Insights: head and neck cancers, version 1.2022. J Natl Compr Canc Netw. 2022;20(3):224–234. doi:10.6004/jnccn.2022.0016 - DOI - PubMed
    1. Graboyes EM, Kompelli AR, Neskey DM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166–177. doi:10.1001/jamaoto.2018.2716 - DOI - PMC - PubMed
    1. Voora RS, Stramiello JA, Sumner WA, et al. Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients. Head Neck. 2021;43(11):3530–3539. doi:10.1002/hed.26852 - DOI - PubMed
    1. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–578. doi:10.1016/s0360-3016(01)01690-x - DOI - PubMed

MeSH terms

LinkOut - more resources